Overview

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study will compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with febuxostat to febuxostat alone in patients with tophaceaous gout.
Phase:
Phase 3
Details
Lead Sponsor:
Ardea Biosciences, Inc.
Treatments:
Febuxostat
Lesinurad